Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: A prospective cohort study

Metabolic Brain Disease

Volumn 29, Issue 2, 2014, Pages 269-279

  Carlson, Renee Donahue ^a   Rolfes, Melissa A ^a   Birkenkamp, Kate E ^a   Nakasujja, Noeline ^b   Rajasingham, Radha ^a,b   Meya, David B ^a,b   Boulware, David R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

AIDS; Cerebrospinal fluid; Cryptococcal meningitis; Intellectual disability; Neurobehavioral manifestations; Neurologic manifestations; Patient outcome assessment

Indexed keywords

AMPHOTERICIN B; EFAVIRENZ; FLUCONAZOLE; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID CULTURE; CLINICAL TRIAL; COGNITION; COHORT ANALYSIS; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; EXECUTIVE FUNCTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SURVIVOR; TREATMENT OUTCOME; COGNITION DISORDERS; FOLLOW UP; HIV INFECTIONS; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; YOUNG ADULT;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COGNITION DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901606741     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9476-1     Document Type: Article

References (42)

1. Ala TA, Doss RC, Sullivan CJ (2004) Reversible dementia: a case of cryptococcal meningitis masquerading as Alzheimer 's disease. J Alzheimers Dis 6(5):503-508 (Pubitemid 40921721)
2. Batista Leite AG, Vidal JE, Filho FB, Nogueira RS, Penalva de Oliveira AC (2004) Cerebral infarction related to cryptococcal meningitis in an HIV-infected patient: case report and literature review. Braz J Infect Dis 9(2):175-179
3. Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, Harrison T (2007) Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 45(1):76-80. doi:10.1086/518607 (Pubitemid 46984619)
4. Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, Teparrakkul P, Loyse A, White NJ, Wood R, Jaffar S, Harrison T (2009a) Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 23(6):701-706. doi:10.1097/QAD.0b013e32832605fe
5. Bicanic T, Muzoora C, Brouwer AE, Meintjes G, Longley N, Taseera K, Rebe K, Loyse A, Jarvis J, Bekker LG, Wood R, Limmathurotsakul D, Chierakul W, Stepniewska K, White NJ, Jaffar S, Harrison TS (2009b) Independent association between rate of clearance of infection and clinical outcome of HIVassociated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis 49(5):702-709. doi:10.1086/604716
6. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, Lee SJ, Kambugu A, Janoff EN, Bohjanen PR (2010) Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med 7(12):e1000384. doi:10.1371/journal.pmed.1000384
7. Butler EK, Boulware DR, Bohjanen PR, Meya DB (2012) Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda. PLoS One 7(12):e51291. doi:10.1371/journal.pone.0051291
8. Chen CH, Chang CC, Chang WN, Tsai NW, Lui CC, Lin WC, Chen NC, Chen C, Huang CW, Lu CH (2012) Neuro-psychological sequelae in HIV-negative cryptococcal meningitis after complete anti-fungal treatment. Acta Neurol Taiwan 21(1):8-17
9. Claus JJ, Portegies P (1998) Reversible blindness in AIDS-related cryptococcal meningitis. Clin Neurol Neurosurg 100:51-52 (Pubitemid 28236528)
10. D'Elia LF, Satz P, Uchiyama CL, White T (1996) Color trails test: professional manual. Psychological Assessment Resources, Odessa
11. Durski KN, Kuntz KM, Yasukawa K, Virnig BA, Meya DB, Boulware DR (2013) Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr 63(3):e101-e108. doi:10.1097/QAI. 0b013e31828e1e56
12. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25(14):1747-1751. doi:10.1097/QAD.0b013e32834a40cd
13. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, Riser L, Hamill R, Dismukes W (2000) Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 30(1):47-54 (Pubitemid 30067061)
14. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR (2010) Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 10(11):791-802. doi:10.1016/S1473-3099(10)70170-5
15. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10(3):317-331. doi:10.1017/s1355617704102130 (Pubitemid 38779804)
16. Hoffmann M, Muniz J, Carroll E, De Villasante J (2009) Cryptococcal meningitis misdiagnosed as Alzheimer's disease: complete neurological and cognitive recovery with treatment. J Alzheimers Dis 16(3):517-520. doi:10.3233/jad-2009-0985
17. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS (2010) Adult meningitis in a setting of high HIVand TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 10:67. doi:10.1186/1471-2334-10-67
18. Johnston SR, Corbett EL, Foster O, Ash S, Cohen J (1992) Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. J Infect 24(2):185-189
19. Kaharuza MF, Bunnell R, Moss S, Purcell WD, Bikaako-Kajura W, Wamai N, Downing R, Solberg P, Coutinho A, Mermin J (2006) Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav 10(S105-111)
20. Kambugu A, Meya DB, Rhein J, O'Brien M, Janoff EN, Ronald AR, Kamya MR, Mayanja-Kizza H, Sande MA, Bohjanen PR, Boulware DR (2008) Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 46(11):1694-1701. doi:10.1086/587667 (Pubitemid 351706766)
21. Klove H (1963) Clinical neuropsychology. Med Clin North Am 47:1647-1658
22. Kwartler JA, Linthicum FH, Jahn AF, Hawke M (1991) Sudden hearing loss due to AIDS-related cryptococcal meningitis-a temporal bone study. Otolaryngol Head Neck Surg 104(2):265-269
23. Levine AJ, Miller EN, Becker JT, Selnes OA, Cohen BA (2004) Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol 18(3):373-384. doi:10.1080/1385404049052420 (Pubitemid 39577274)
24. Levine AJ, Hinkin CH, Ando K, Santangelo G, Martinez M, Valdes-Sueiras M, Saxton EH, Mathisen G, Commins DL, Moe A, Singe CFJ (2008) An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults. J Clin Exp Neuropsychol 30(7):836-843. doi:10.1080/13803390701819036
25. Lu CH, Chen HL, Chang WN, Tsai NW, Wang HC, Yang TM, Lin YJ, Lin CP, Chen CC, Cheng BC, Lin WC (2011) Assessing the chronic neuropsychologic sequelae of human immunodeficiency virus-negative cryptococcal meningitis by using diffusion tensor imaging. AJNR Am J Neuroradiol 32(7):1333-1339. doi:10.3174/ajnr.A2489
26. Maj M, D'Elia L, Satz P, Janssen R, Zaudig M, Uchiyama C, Starace F, Galderisi S, Chervinsky A (1993) Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol 8(2):123-135 (Pubitemid 23079256)
27. Motoyoshi A, Nakajima H, Takano K, Moriyama M, Kannan Y, Nakamura Y (2008) Effects of Amphotericin B on the expression of neurotoxic and neurotrophic factors in cultured microglia. Neurochem Int 52(6):1290-1296. doi:10.1016/j.neuint.2008.01.012
28. Myer L, Smit J, Liezel LR, Parker S, Sein DJ, Seedat S (2008) Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS 22(2):146-158
29. Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, Katabira E, Clifford DB, Sacktor N (2010)Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry 10(1):44. doi:10.1186/1471-244x-10-44
30. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23(4):525-530. doi:10.1097/QAD. 0b013e328322ffac
31. Radloff LS (1977) The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 3(1):385-401
32. Razonable RR, Henault M, Lee LN, Laethem C, Johnston PA, Watson HL, Paya CV (2005) Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother 49(4):1617-1621. doi:10.1128/AAC.49.4.1617-1621. 2005 (Pubitemid 40463404)
33. Reitan RM (1969) Manual for administration of neuropsychological test batteries for adults and children. Indiana University Press, Bloomington
34. Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD (2004) Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36(1):562-566 (Pubitemid 38544504)
35. Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW (2006) Timed Gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol 28(7):1053-1064. doi:10.1080/13803390500205684 (Pubitemid 44091926)
36. Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, Ronald A, Sacktor N (2007) Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 7:8. doi:10.1186/1471-2377-7-8
37. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids 19(13):1367-1374 (Pubitemid 41800672)
38. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311-314. doi:10.1212/01.wnl.0000225183.74521.72 (Pubitemid 44305421)
39. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM (2003) The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 278(39):37561-37568. doi:10.1074/jbc.M306137200 (Pubitemid 37175278)
40. Spreen O, Strauss E (1998) A compendium of neuropsychological tests: administration, norms, and commentary, 2nd edn. Oxford University Press, New York
41. Wechsler D (1981) Wechsler adult intelligence scale-revised. The Psychological Corporation, San Antonio
42. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68(5):350-355. doi:10.1212/01.wnl.0000252811.48891.6d (Pubitemid 46184210)